HQY on Nasdaq
HEALTHEQUITY, INC.
American business services company, incorporated in Delaware.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with MoneyGram, QuinStreet or Envestnet, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
69.5%Gross margin2
24.6%Operating margin2
16.4%Net margin2
9.5%Revenue growth, 20262
10.2%Return on equity2
0.45×Debt to equity2
$455.1MFree cash flow2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Financial Service, Other brought in 48% of the revenue HEALTHEQUITY, INC. broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Financial Service, Other | $386.6M | $545.4M | $636.8M |
| Service | $455.7M | $478.3M | $485.0M |
| Credit and Debit Card | $157.3M | $176.0M | $191.6M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue30¢$400.3M
- Research and development20¢$262.5M
- Other costs28¢$373.2M
- Income tax5¢$62.2M
- Profit16¢$215.2M
Out of $1.3B in revenue.2
Where each dollar of operating cash went, fiscal 2026
- Capital spending0¢$2.0M
- Share buybacks65¢$299.3M
- Kept or used elsewhere34¢$155.9M
Out of $457.1M of cash from operations.2
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-01-31 | 2025-01-31 | 2024-01-31 |
|---|---|---|---|
| Total revenue | $1.3B | $1.2B | $999.6M |
| Total cost of revenue | $400.3M | $422.5M | $376.9M |
| Gross profit | $913.1M | $777.3M | $622.6M |
| Sales and marketing | $95.2M | $90.7M | $79.3M |
| Technology and development | $262.5M | $239.5M | $218.8M |
| General and administrative | $119.9M | $132.3M | $103.7M |
| Amortization of acquired intangible assets | $108.0M | $111.9M | $92.8M |
| Merger integration | $5.0M | $40.5M | $10.4M |
| Total operating expenses | $590.7M | $614.9M | $504.9M |
| Income from operations | $322.5M | $162.3M | $117.7M |
| Interest expense | -$57.1M | -$60.6M | -$55.5M |
| Other income, net | $12.1M | $14.3M | $12.8M |
| Total other expense | -$45.0M | -$46.3M | -$42.7M |
| Income before income taxes | $277.4M | $116.0M | $75.0M |
| Income tax provision | $62.2M | $19.3M | $19.3M |
| Net income | $215.2M | $96.7M | $55.7M |
| Basic (in usd per share) | $2.50 | $1.11 | $0.65 |
| Diluted (in usd per share) | $2.46 | $1.09 | $0.64 |
| Basic (in shares) | 86.1M shares | 86.9M shares | 85.6M shares |
| Diluted (in shares) | 87.5M shares | 88.8M shares | 87.0M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $318.9M | $295.9M | ||
| Accounts receivable, net of allowance for doubtful accounts of $924 and $2,070 as of January 31, 2026 and 2025, respectively | $123.7M | $118.0M | ||
| Prepaid expenses and other current assets | $69.7M | $63.8M | ||
| Total current assets | $512.3M | $477.7M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use assets | $36.3M | $43.2M | ||
| Intangible assets, net | $1.1B | $1.2B | ||
| Goodwill | $1.6B | $1.6B | ||
| Other assets | $83.2M | $71.6M | ||
| Total assets | $3.4B | $3.4B | ||
| Accounts payable | $12.2M | $14.4M | ||
| Accrued compensation | $60.4M | $69.3M | ||
| Accrued liabilities | $74.4M | $62.6M | ||
| Operating lease liabilities | $9.9M | $10.0M | ||
| Total current liabilities | $156.8M | $156.3M | ||
| Long-term debt, net of issuance costs | $957.4M | $1.1B | ||
| Operating lease liabilities, non-current | $34.2M | $42.2M | ||
| Other long-term liabilities | $31.0M | $23.0M | ||
| Deferred tax liability | $93.7M | $55.8M | ||
| Total long-term liabilities | $1.1B | $1.2B | ||
| Total liabilities | $1.3B | $1.3B | ||
| Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2026 and 2025 | $0 | $0 | ||
| Common stock, $0.0001 par value, 900,000 shares authorized, 85,007 and 86,536 shares issued and outstanding as of January 31, 2026 and 2025, respectively | $8.0K | $9.0K | ||
| Additional paid-in capital | $1.9B | $1.9B | ||
| Accumulated earnings | $195.9M | $209.3M | ||
| Accumulated other comprehensive loss | -$5.7M | $0 | ||
| Total stockholders equity | $2.1B | $2.1B | $2.0B | $1.9B |
| Total liabilities and stockholders equity | $3.4B | $3.4B | ||
| Accounts receivable, allowance for doubtful accounts | $924.0K | $2.1M | ||
| Preferred stock par value (in usd per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value per share (in usd per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 900.0M shares | 900.0M shares | ||
| Common stock, shares issued (in shares) | 85.0M shares | 86.5M shares | ||
| Common stock, shares outstanding (in shares) | 85.0M shares | 86.5M shares |
| Period ending | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $318.9M | $295.9M | ||
| Accounts receivable, net of allowance for doubtful accounts of $924 and $2,070 as of January 31, 2026 and 2025, respectively | $123.7M | $118.0M | ||
| Prepaid expenses and other current assets | $69.7M | $63.8M | ||
| Total current assets | $512.3M | $477.7M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use assets | $36.3M | $43.2M | ||
| Intangible assets, net | $1.1B | $1.2B | ||
| Goodwill | $1.6B | $1.6B | ||
| Other assets | $83.2M | $71.6M | ||
| Total assets | $3.4B | $3.4B | ||
| Accounts payable | $12.2M | $14.4M | ||
| Accrued compensation | $60.4M | $69.3M | ||
| Accrued liabilities | $74.4M | $62.6M | ||
| Operating lease liabilities | $9.9M | $10.0M | ||
| Total current liabilities | $156.8M | $156.3M | ||
| Long-term debt, net of issuance costs | $957.4M | $1.1B | ||
| Operating lease liabilities, non-current | $34.2M | $42.2M | ||
| Other long-term liabilities | $31.0M | $23.0M | ||
| Deferred tax liability | $93.7M | $55.8M | ||
| Total long-term liabilities | $1.1B | $1.2B | ||
| Total liabilities | $1.3B | $1.3B | ||
| Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2026 and 2025 | $0 | $0 | ||
| Common stock, $0.0001 par value, 900,000 shares authorized, 85,007 and 86,536 shares issued and outstanding as of January 31, 2026 and 2025, respectively | $8.0K | $9.0K | ||
| Additional paid-in capital | $1.9B | $1.9B | ||
| Accumulated earnings | $195.9M | $209.3M | ||
| Accumulated other comprehensive loss | -$5.7M | $0 | ||
| Total stockholders equity | $2.1B | $2.1B | $2.0B | $1.9B |
| Total liabilities and stockholders equity | $3.4B | $3.4B | ||
| Accounts receivable, allowance for doubtful accounts | $924.0K | $2.1M | ||
| Preferred stock par value (in usd per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value per share (in usd per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 900.0M shares | 900.0M shares | ||
| Common stock, shares issued (in shares) | 85.0M shares | 86.5M shares | ||
| Common stock, shares outstanding (in shares) | 85.0M shares | 86.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-01-31 | 2025-01-31 | 2024-01-31 |
|---|---|---|---|
| Net income | $215.2M | $96.7M | $55.7M |
| Depreciation and amortization | $154.7M | $162.5M | $153.1M |
| Stock-based compensation | $73.1M | $96.4M | $77.2M |
| Amortization of debt issuance costs | $1.1M | $2.1M | $2.9M |
| Amortization of gains on derivatives | -$16.0K | $0 | $0 |
| Loss on extinguishment of debt | $0 | $1.6M | $1.2M |
| Deferred taxes | $39.7M | -$12.8M | -$14.0M |
| Accounts receivable | -$5.7M | -$13.1M | -$8.1M |
| Prepaid expenses and other current and non-current assets | -$12.7M | -$11.8M | -$32.8M |
| Operating lease right-of-use assets | $6.8M | $6.7M | $10.2M |
| Accrued compensation | -$8.8M | $17.8M | $3.0M |
| Accounts payable, accrued liabilities, and other current liabilities | $1.7M | $8.9M | -$204.0K |
| Operating lease liabilities, non-current | -$8.0M | -$7.8M | -$11.8M |
| Other long-term liabilities | $48.0K | -$7.2M | $6.6M |
| Net cash provided by operating activities | $457.1M | $339.9M | $242.8M |
| Purchases of software and capitalized software development costs | -$46.5M | -$51.1M | -$41.1M |
| Purchases of property and equipment | -$2.0M | -$2.1M | -$1.7M |
| Acquisitions of HSA portfolios | -$293.0K | -$452.2M | -$3.3M |
| Settlement of derivatives, net | $1.6M | $0 | $0 |
| Net cash used in investing activities | -$47.1M | -$505.5M | -$46.1M |
| Principal payments on long-term debt | -$100.0M | -$561.9M | -$54.4M |
| Repurchases of common stock | -$299.3M | -$121.5M | $0 |
| Proceeds from long-term debt | $0 | $736.9M | $0 |
| Payment of debt issuance costs | $0 | -$3.7M | $0 |
| Settlement of client-held funds obligation, net | $867.0K | -$1.6M | $865.0K |
| Proceeds from exercise of common stock options | $11.4M | $9.4M | $6.5M |
| Net cash provided by (used in) financing activities | -$387.0M | $57.6M | -$47.0M |
| Increase (decrease) in cash and cash equivalents | $23.0M | -$108.0M | $149.7M |
| Interest expense paid in cash | $52.2M | $58.6M | $49.6M |
| Income tax payments, net | $8.0M | $26.1M | $35.4M |
| Purchases of software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation | $4.3M | $6.0M | $3.1M |
| Purchases of property and equipment included in accounts payable or accrued liabilities | $16.0K | $45.0K | $263.0K |
| Repurchases of common stock included in accrued liabilities | $3.2M | $754.0K | $0 |
| Non-cash purchase consideration related to acquisitions of HSA portfolios | $0 | $20.3M | $0 |
| Settlement of derivatives included in other current assets | $2.5M | $0 | $0 |
| Exercise of common stock options receivable | $0 | $10.0K | $429.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led HEALTHEQUITY, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
201520202025
- Chief executive officerScott Cutler Jan 10, 2025 to now12
- Chief executive officerDarcy G. Mott Jul 30, 2014 to Jul 30, 201413
- PresidentScott Cutler Jan 10, 2025 to now12
- Chief financial officerJames M. Lucania Sep 7, 2023 to now14
- Chief financial officerTyson D. Murdock Apr 1, 2021 to Jul 7, 202315
- Chief financial officerDarcy G. Mott Aug 7, 2014 to Apr 1, 202116
- Chief operating officerEdward Bloomberg Aug 15, 2018 to Aug 3, 202217
Board members and other officers (33)
- EVP Chief Prod & Strat OfficerSunil Rajasekar May 12, 2026 to now18
- Chief Customer OfficerMichael Gathright Jul 14, 2025 to now19
- EVP, Chief Security OfficerSlim Aissi Jan 25, 2024 to Mar 29, 202420
- EVP, CHIEF COMMERCIAL OFFICERMichael Henry Fiore Mar 29, 2024 to now21
- EVP, Chief Technology OfficerElimelech Rosner Mar 17, 2022 to now22
- EVP Chief Marketing OfficerAdam J. Hostetter Apr 19, 2019 to Jul 1, 202123
- Exec VP, OperationsAngelique Christine Hill Apr 25, 2018 to Apr 7, 202124
- EVP Chief Security OfficerLarry L. Trittschuh Dec 19, 2018 to Jul 7, 202325
- EVP, Chief Marketing OfficerGary D. Robinson Apr 6, 2017 to Jun 11, 201826
- Executive VP of SalesWilliam Robert Otten May 11, 2017 to Aug 3, 202127
- Executive VP, GC & Corp. Secy.Delano Ladd Sep 12, 2016 to Jul 8, 202428
- Exec VP, OperationsJon Soldan Sep 2, 2015 to Mar 29, 201829
- Executive VP, CTO and CIOAshley Dreier Jul 30, 2014 to Apr 8, 202030
- Exec VP of Sales & MarketingEdward Craig Keohan Jul 30, 2014 to Jul 30, 201431
- Vice chairStephen Neeleman Jul 30, 2014 to now32
- Executive VP, GC & Corp. Secy.Frode Jensen Aug 7, 2014 to Mar 25, 201633
- Exec VP, Sales & MarketingMatthew Sydney Nov 3, 2014 to Nov 3, 201634
- Board memberWilliam Gassen Mar 30, 2026 to now35
- Board memberNoemie Clemence Heuland Sep 30, 2026 to now36
- Board memberScott Cutler Jan 10, 2025 to now12
- Board memberRajesh Natarajan May 4, 2022 to now37
- Board memberDebra Charlotte McCowan Apr 3, 2018 to now38
- Board memberGayle Furgurson Wellborn Sep 19, 2017 to now39
- Board memberAdrian T. Dillon Sep 6, 2016 to now40
- Board memberRobert W. Selander Oct 1, 2015 to now41
- Board memberFrank Corvino Jul 30, 2014 to Sep 26, 202342
- Board memberFrank Medici Jul 30, 2014 to Nov 20, 202043
- Board memberIan Sacks Jul 30, 2014 to Feb 3, 202344
- Board memberManu S. Rana Jul 30, 2014 to Aug 2, 201745
- Board memberMike Leavitt Jul 30, 2014 to Aug 2, 201746
- Board memberStephen Neeleman Jul 30, 2014 to now32
- Board memberEvelyn S. Dilsaver Aug 7, 2014 to now47
- General counselDelano Ladd Oct 7, 2024 to now48
Former names
- HEALTHEQUITY INCFeb 22, 2008 to Jun 6, 20193
Timeline
Filings
522 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 66 major events, 280 insider forms, 20 large holders, 136 other. The latest 20:
- Oct 9, 20268-K EDGAR
- Oct 9, 2026SCHEDULE 13G/A EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Oct 8, 20264 EDGAR
- Oct 8, 2026144 EDGAR
- Sep 30, 20263 EDGAR
- Sep 30, 20268-K EDGAR
- Sep 18, 20264 EDGAR
- Aug 27, 2026S-8 EDGAR
- Aug 27, 202610-Q EDGAR
- Aug 27, 20268-K EDGAR
The 522 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 20 such filings since October 2021, the latest 10:
- Oct 9, 2026SCHEDULE 13G/A
- Jul 31, 2026SCHEDULE 13G/A
- Jul 15, 2026SCHEDULE 13G/A
- Apr 30, 2026SCHEDULE 13G
- Apr 29, 2026SCHEDULE 13G
- Mar 27, 2026SCHEDULE 13G/A
- Nov 5, 2025SCHEDULE 13G/A
- Feb 13, 2024SC 13G/A
- Feb 9, 2024SC 13G/A
- Feb 9, 2024SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 11,277,914 | $1.0B | 0.0% | +745,520 |
| Wasatch Advisors LP | 7,960,735 | $719.0M | 4.7% | +757,801 |
| Morgan Stanley | 4,547,219 | $410.7M | 0.0% | +2,061,306 |
| Vanguard Portfolio Management LLC | 4,057,643 | $366.5M | 0.0% | −105,950 |
| Vanguard Capital Management LLC | 3,640,776 | $328.8M | 0.0% | −183,028 |
| State Street Corp | 3,241,046 | $292.7M | 0.0% | +141,149 |
| Geode Capital Management, LLC | 2,374,467 | $214.5M | 0.0% | +114,821 |
| Aqr Capital Management LLC | 1,999,209 | $176.1M | 0.1% | −93,014 |
| Dimensional Fund Advisors LP | 1,869,036 | $168.8M | 0.0% | +241,997 |
| William Blair Investment Management, LLC | 1,773,227 | $160.2M | 0.5% | +113,611 |
| Fmr LLC | 1,538,387 | $138.9M | 0.0% | +403,454 |
| Brown Advisory Inc | 1,372,624 | $124.0M | 0.2% | −40,160 |
| Clearbridge Investments, LLC | 1,296,765 | $117.1M | 0.1% | −13,207 |
| Charles Schwab Investment Management Inc | 1,188,902 | $107.4M | 0.0% | +13,563 |
| Greenhouse Funds LLLP | 1,183,024 | $106.9M | 5.6% | −74,830 |
| Geneva Capital Management LLC | 1,149,680 | $103.8M | 2.4% | −24,390 |
| Bank Of America Corp /de/ | 1,146,735 | $103.6M | 0.0% | +284,727 |
| Jpmorgan Chase & Co | 1,158,837 | $102.1M | 0.0% | −24,574 |
| DAVENPORT & Co LLC | 1,087,218 | $98.2M | 0.5% | +71,784 |
| Northern Trust Corp | 1,072,119 | $96.8M | 0.0% | +35,945 |
| Goldman Sachs Group Inc | 1,007,434 | $91.0M | 0.0% | +206,616 |
| Arrowstreet Capital, Limited Partnership | 965,807 | $87.2M | 0.0% | +963,026 |
| Atalan Capital Partners, LP | 915,270 | $82.7M | 5.1% | +31,600 |
| Loomis Sayles & Co L P | 908,554 | $82.1M | 0.1% | −23,352 |
| Jupiter Topco LLC | 872,972 | $78.8M | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
24 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jul 10, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −4.2% | Report |
| Jun 30, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −0.9% | Report |
| May 29, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | +3.1% | Report |
| Jun 17, 2025 | Lisa C. McClainRepublican, House | Sale | $1,001 - $15,000 | +36.7% | Report |
| Jun 16, 2025 | Gilbert Ray Cisneros, Jr.Democratic, House | Partial sale | $1,001 - $15,000 | +36.5% | Report |
| Jun 11, 2025 | Lisa C. McClainRepublican, House | Buy | $1,001 - $15,000 | −39.9% | Report |
| Jan 13, 2025 | Robert P. Bresnahan, Jr.Republican, House | Sale | $1,001 - $15,000 | +41.9% | Report |
| Nov 7, 2024 | Josh GottheimerDemocratic, House | Partial sale | $1,001 - $15,000 | +34.4% | Report |
| Jun 21, 2024 | Josh GottheimerDemocratic, House | Partial sale | $1,001 - $15,000 | +31.1% | Report |
| Jan 19, 2024 | Blake D. MooreRepublican, House | Sale | $1,001 - $15,000 | +33.5% | Report |
| Jan 19, 2024 | Blake D. MooreRepublican, House | Sale | $1,001 - $15,000 | +33.5% | Report |
| Apr 10, 2023 | Daniel S. GoldmanDemocratic, House | Sale | $15,001 - $50,000 | +27.8% | Report |
| Jan 10, 2022 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | +21.0% | Report |
| Dec 9, 2021 | Josh GottheimerDemocratic, House | Partial sale | $1,001 - $15,000 | −54.4% | Report |
| May 12, 2021 | Blake D. MooreRepublican, House | Buy | $1,001 - $15,000 | −64.7% | Report |
| May 11, 2021 | Blake D. MooreRepublican, House | Buy | $1,001 - $15,000 | −58.1% | Report |
| Apr 30, 2021 | Blake D. MooreRepublican, House | Buy | $1,001 - $15,000 | −63.2% | Report |
| Mar 26, 2021 | Blake D. MooreRepublican, House | Buy | $1,001 - $15,000 | −62.7% | Report |
| Jul 17, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −81.1% | Report |
| Jul 9, 2020 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −80.4% | Report |
| Apr 7, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −90.0% | Report |
| Apr 3, 2020 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −85.8% | Report |
| Mar 31, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −116.6% | Report |
| Mar 26, 2020 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −131.5% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29SEC EDGARJon Soldan, Exec VP, Operations
- 30
- 31
- 32SEC EDGARStephen Neeleman, Vice chair
- 33
- 34
- 35SEC EDGARWilliam Gassen, Board member
- 36
- 37SEC EDGARRajesh Natarajan, Board member
- 38
- 39
- 40SEC EDGARAdrian T. Dillon, Board member
- 41SEC EDGARRobert W. Selander, Board member
- 42SEC EDGARFrank Corvino, Board member
- 43SEC EDGARFrank Medici, Board member
- 44SEC EDGARIan Sacks, Board member
- 45SEC EDGARManu S. Rana, Board member
- 46SEC EDGARMike Leavitt, Board member
- 47SEC EDGAREvelyn S. Dilsaver, Board member
- 48SEC EDGARDelano Ladd, General counsel